GLOBAL

pharmaceuticals, namely, promethazine, for treatment of allergic reactions and for control of nausea and vomiting; chloroquine, for treatment of malaria and extraintestinal amebiasis; prednisolone, for treatment of adrenocortical insufficiency, rheumatic disorders and collagen diseases; tetracycline, for treatment of infections caused by gram-negative microorganisms; methyltestosterone, for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone such as in delayed puberty; meprobamate, for management of anxiety disorders; hydrocortisone, for replacement therapy in adrenocortical therapy and as anti-inflammatory agent in disorders of many organ systems; hyoscyamine, for adjunctive therapy in treatment of peptic ulcer and for control of gastric secretion in spastic colitis; chlordiazepoxide, for relief of anxiety and tension; piperazine, for treatment of roundworms and pinworms; pancrealipase; for treatment of chronic pancreatitis and cystic fibrosis; vitamins and nutritional supplements, namely, calcium gluconate, ferrous gluconate, shark cartilage, melatonin, collagen and fish liver oil